Skip to content

Clinical trials

Brain Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20071
20152
20162
20171
20181
20201
20213
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting7
Recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
AstraZeneca2
Bayer2
Eli Lilly and Company2
Sumitomo Pharma America, Inc.2
Blueprint Medicines Corporation1
HUYABIO International, LLC.1
Haruhiko Fukuda1
HeadSense Medical1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms21
Glioma5
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Glioblastoma4
Melanoma4
Breast Neoplasms3
Colorectal Neoplasms2
Lung Neoplasms2
Pancreatic Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.